5-157460218-CTCGC-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001099287.2(NIPAL4):c.-103_-99delinsT variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Consequence
NIPAL4
NM_001099287.2 5_prime_UTR
NM_001099287.2 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.61
Genes affected
NIPAL4 (HGNC:28018): (NIPA like domain containing 4) This gene likely encodes a membrane receptor. Mutations in this gene have been associated with autosomal recessive congenital ichthyosis. [provided by RefSeq, Feb 2010]
ADAM19 (HGNC:197): (ADAM metallopeptidase domain 19) This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. This member is a type I transmembrane protein and serves as a marker for dendritic cell differentiation. It has been demonstrated to be an active metalloproteinase, which may be involved in normal physiological processes such as cell migration, cell adhesion, cell-cell and cell-matrix interactions, and signal transduction. It is proposed to play a role in pathological processes, such as cancer, inflammatory diseases, renal diseases, and Alzheimer's disease. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NIPAL4 | NM_001099287.2 | c.-103_-99delinsT | 5_prime_UTR_variant | 1/6 | ENST00000311946.8 | NP_001092757.2 | ||
NIPAL4 | NM_001172292.2 | c.-103_-99delinsT | 5_prime_UTR_variant | 1/5 | NP_001165763.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NIPAL4 | ENST00000311946.8 | c.-103_-99delinsT | 5_prime_UTR_variant | 1/6 | 1 | NM_001099287.2 | ENSP00000311687 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 23, 2021 | Variant summary: NIPAL4 c.84_88delinsT (p.Ser29AlafsX133) results in a frameshift in the first exon of the longest protein isoform (NM_001099287.1) of NIPAL4. However, the variant is located in the untranslated mRNA region (c.-103_-99delinsT) upstream of the initiation codon in the shorter (canonical) protein isoform (NM_001099287.2) of NIPAL4. The variant was absent in 125568 control chromosomes (gnomAD). To our knowledge, no occurrence of c.84_88delinsT in individuals affected with Lamellar Ichthyosis and no experimental evidence demonstrating its impact on protein function have been reported. However, upstream from this position, a start-loss variant affecting the longer isoform, c.2T>C (p.Met1?), has been reported in a homozygous patient (PMID: 31347739; this variant would correspond to c.-185T>C in the shorter isoform). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.